Associate Director, Clinical Supply Chain jobs in United States
cer-icon
Apply on Employer Site
company-logo

Janux Therapeutics · 15 hours ago

Associate Director, Clinical Supply Chain

Janux Therapeutics is seeking an Associate Director of Supply Chain responsible for the strategic operational oversight of clinical supply chain activities. This role involves collaborating with various departments to ensure timely drug supply for clinical programs and managing inventory, distribution, and regulatory compliance.

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Responsibilities

Develop and implement clinical supply strategies and oversee distribution and inventory of clinical trial material to ensure uninterrupted IMP supply to clinical sites and minimize product waste throughout the duration of the clinical trial
Provide strategic direction for clinical supply planning to establish IRT system requirements IRT system specifications and contribute to the cross-functional review and approval of IRT user acceptance testing (UAT)
Develop and manage forecasts and inventory strategies; analyze actual spend against projections to support accurate budget forecasting and ensure operations remain within financial targets
Collaborate with cross-functional departments to create and approve labeling designs in alignment with regulatory framework
Manage packaging activities at CPO and collaborate with QA team for release
Contribute to the preparation and review of clinical trial pharmacy manuals and packaging batch records
Oversees distribution and inventory of clinical trial material
Manage drug return, destruction process, and accountability at the depots
Manage logistics and execution of material shipments from CDMOs to depots, testing facilities, and CPOs
Responsible for timely review and approval of third-party vendor invoices, ensuring accuracy, contractual compliance and alignment with financial controls
Collaborate with Quality Assurance team on Quality Events investigations, deviations/CAPA, Batch Record Review and drug disposition as required. Manage expiry date extensions, documentation, and distribution activities
Participate in forecast meetings with Clinical Operations including the preparation of slides and communication of inventory updates and operational strategies
Identify and lead process improvement initiatives
Other duties as deemed necessary

Qualification

Clinical supply chain managementInventory managementGlobal clinical supply distributionData visualization platformsClinical supply softwareVendor oversightScientific degreeProcess improvementClinical research protocolCross-functional collaboration

Required

Bachelor's degree in scientific or pharmaceutical discipline
8+ years of biotechnology/pharmaceutical industry experience with direct experience in clinical supply chain management
Inventory management and vendor oversight experience in Phase I-III clinical trials required
Global clinical supply distribution experience required
Experience using data visualization platforms or clinical supply software for management of operational logistics, inventory, and forecasting
Experience managing various products and sample shipping and receiving from and between CDMOs, CPOs, depots
Ability to evaluate clinical study assumptions and providing clinical supply forecasts to support manufacturing plans and budget endorsement
Demonstrated understanding of clinical research protocol requirements and experience developing IRT specifications

Benefits

Annual bonus program
Incentive stock option plan
401k plan with flat non-elective employer contribution
Comprehensive medical insurance with 90-100% employer-paid premiums
Dental and vision insurance
HSA, FSA, and supplemental insurance plans (life, disability, accident, critical illness, hospital indemnity)
Unlimited PTO
Generous holiday schedule; includes summer and winter company shutdown
Relocation assistance

Company

Janux Therapeutics

twittertwitter
company-logo
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Funding

Current Stage
Public Company
Total Funding
$898.94M
Key Investors
RA Capital ManagementAvalon Ventures
2024-12-03Post Ipo Equity· $350M
2024-02-29Post Ipo Equity· $296.5M
2023-07-17Post Ipo Equity· $60M

Leadership Team

leader-logo
David Campbell
President, CEO & Director (Founder)
linkedin
leader-logo
Byron Robinson
Chief Strategy Officer
linkedin
Company data provided by crunchbase